{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:53:12Z","timestamp":1787921592173,"version":"build-2784847793"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Virological failure on first-line antiretroviral therapy (ART) remains a major challenge in the management of HIV\/AIDS in resource-limited settings, including Ethiopia. However, the prevalence of virological failure and its associated factors among adult patients on first-line ART in West Hararghe, Ethiopia, are not well documented. Therefore, this study aimed to assess virological treatment failure and its determinants among people living with HIV (PWH) in West Hararghe, Eastern Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using routine HIV-related data from a health facility providing services in West Hararghe between 01 January 2017 and 31 December 2020. Sociodemographic, behavioral, clinical, and HIV-related data were collected through medical chart reviews. Virological treatment failure was defined as a plasma viral load above 1,000 copies\/mL based on two consecutive viral load measurements. A logistic regression model was used to identify factors associated with virological treatment failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 257 records of PWH were reviewed and included in this analysis. Of these, 11.67% experienced virological failure while on first-line ART. Baseline undernutrition (AOR\u202f=\u202f3.717: 1.051, 13.139), non-disclosure of serostatus (AOR\u202f=\u202f4.453: 1.340, 14.793), early (\u2264 30\u202fdays) ART initiation (AOR\u202f=\u202f0.235: 0.064, 0.859), a history of missed daily ART doses (AOR\u202f=\u202f3.156: 1.007, 9.891), and the use of a dolutegravir (DTG)-based regimen (AOR\u202f=\u202f0.275: 0. 085, 0.895) were statistically associated with virological failure on first-line ART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Virological failure on first-line ART was found to be significantly high in West Hararghe. Factors such as undernutrition, non-disclosure of serostatus, interruption of ART doses, and the use of DTG-based regimens were identified as significant predictors of virological treatment failure. Healthcare providers should focus on the accelerated initiation of ART (preferably with a DTG-based regimen) and supplemental nutritional therapy for patients with undernutrition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1440504","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:22:13Z","timestamp":1748827333000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Virological treatment failure and associated factors among adults on first-line antiretroviral therapy in West Hararghe, Ethiopia"],"prefix":"10.3389","volume":"13","author":[{"given":"Ebisa","family":"Zerihun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenesa","family":"Tesema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fekadu","family":"Abera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/hiv.12788","article-title":"Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK","volume":"20","author":"Brogan","year":"2019","journal-title":"HIV Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e207954","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref3","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","year":"2016"},{"key":"ref4","volume-title":"Patient monitoring guideline for HIV care and ART","year":"2006"},{"key":"ref5","volume-title":"Data quality assessment of national and partner HIV treatment and patient monitoring data and systems: implementation tool","year":"2018"},{"key":"ref6","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Summary of key features and recommendations, June 2013","year":"2013"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/ijerph20010621","article-title":"Isoniazid preventive therapy for prevention of tuberculosis among people living with HIV in Ethiopia: a systematic review of implementation and impacts","volume":"20","author":"Assefa","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1097\/QAD.0b013e32833ac6bc","article-title":"Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa","volume":"24","author":"Hoffmann","year":"2010","journal-title":"AIDS (London, England)"},{"key":"ref9","volume-title":"National Guidelines for comprehensive HIV prevention","year":"2016"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.23937\/2474-3658\/1510072","article-title":"Incidence and predictors of first line anti-retroviral therapy failure among adults receiving HIV Care in North West Ethiopia: a hospital-based follow-up study","volume":"5","author":"Agezew","year":"2019","journal-title":"J Infect Dis Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1471-2334-14-468","article-title":"The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, Northwest Ethiopia: a retrospective follow-up study","volume":"14","author":"Assefa","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0164299","DOI":"10.1371\/journal.pone.0164299","article-title":"Predictors of treatment failure among adult antiretroviral treatment (ART) clients in bale zone hospitals, south eastern Ethiopia","volume":"11","author":"Haile","year":"2016","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-6113.1000749","article-title":"Incidence and predictors of anti-retroviral treatment (ART) failure among adults receiving HIV Care at Zewditu Memorial Hospital, Addis Ababa, Ethiopia","volume":"8","author":"Sisay","year":"2017","journal-title":"J AIDS Clin Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4732-6","article-title":"HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study","volume":"20","author":"Desta","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e017413","DOI":"10.1136\/bmjopen-2017-017413","article-title":"Immunological failure in people with HIV (PWH) adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study","volume":"8","author":"Gesesew","year":"2018","journal-title":"BMJ Open"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"577049","DOI":"10.1101\/577049","article-title":"Treatment failure among people living with HIV taking antiretroviral therapy in Ethiopia","author":"Getaneh","year":"2019","journal-title":"BioRxiv"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1186\/s12889-019-7078-5","article-title":"Clinical and immunological failure among HIV-positive adults taking first-line antiretroviral therapy in Dire Dawa, eastern Ethiopia","volume":"19","author":"Lenjiso","year":"2019","journal-title":"BMC Public Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/pathogens8040161","article-title":"Rates and correlates of short term Virologic response among treatment-Na\u00efve people with HIV (PWH) children initiating antiretroviral therapy in Ethiopia: a multi-center prospective cohort study","volume":"8","author":"Tadesse","year":"2019","journal-title":"Pathogens"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12879-019-3924-4","article-title":"Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study","volume":"19","author":"Ahmed","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1097\/QAD.0000000000000236","article-title":"Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure","volume":"28","author":"Rutherford","year":"2014","journal-title":"AIDS"},{"key":"ref21","volume-title":"National Guidelines for comprehensive HIV prevention","year":"2018"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-020-00294-z","article-title":"Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, Northeast Ethiopia","volume":"17","author":"Nega","year":"2020","journal-title":"AIDS Res Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cid\/ciy400","article-title":"Nationwide cohort study of antiretroviral therapy timing: treatment dropout and Virological failure in China, 2011\u20132015","volume":"68","author":"Zhao","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"Hosmer","year":"2013"},{"key":"ref25","volume-title":"2025 aids targets","year":"2020"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12879-017-2428-3","article-title":"Factors associated with Virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, august 2014\u2013July 2015","volume":"17","author":"Bulage","year":"2017","journal-title":"BMC Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e0196259","DOI":"10.1371\/journal.pone.0196259","article-title":"Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of northern Ethiopia","volume":"13","author":"Hailu","year":"2018","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.2147\/IDR.S280966","article-title":"Virological treatment failure among adult HIV\/AIDS patients from selected hospitals of north Shoa zone, Amhara region, Ethiopia","volume":"13","author":"Derseh","year":"2020","journal-title":"Infect Drug Resist"},{"key":"ref29","first-page":"158","article-title":"A retrospective cross-sectional study on the prevalence and factors associated with virological non-suppression among HIV-positive adult patients on antiretroviral therapy in Woliso town, Oromia, Ethiopia","volume":"15","author":"Haile","year":"2021","journal-title":"Int J Med Health Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0211344","DOI":"10.1371\/journal.pone.0211344","article-title":"HIV virologic failure and its predictors among people with HIV (PWH) adults on antiretroviral therapy in the African cohort study","volume":"14","author":"Kiweewa","year":"2019","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/HIV.S266460","article-title":"Prevalence and predictors of Virological failure among adults living with HIV in south Wollo zone, Northeast Ethiopia: a retrospective cohort study","volume":"12","author":"Wendie","year":"2020","journal-title":"HIV\/AIDS"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/tmi.12563","article-title":"Virological efficacy with first-line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression","volume":"20","author":"Shet","year":"2015","journal-title":"Trop Med Int Health"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05124-1","article-title":"Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study","volume":"20","author":"Yuan","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e0116144","DOI":"10.1371\/journal.pone.0116144","article-title":"Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland","volume":"10","author":"Jobanputra","year":"2015","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e0244066","DOI":"10.1371\/journal.pone.0244066","article-title":"Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia","volume":"15","author":"Plymoth","year":"2020","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S2468-2667(16)30002-0","article-title":"Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses","volume":"1","author":"Burch","year":"2016","journal-title":"Lancet Public Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/QAD.0b013e32834dcee9","article-title":"Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression","volume":"26","author":"Dombrowski","year":"2012","journal-title":"AIDS"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2147\/HIV.S281672","article-title":"Determinants of virological failure among patients on first-line antiretroviral therapy in Central Oromia, Ethiopia: a case\u2013control study","volume":"12","author":"Abdullahi","year":"2020","journal-title":"HIV\/AIDS"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4148-3","article-title":"The effect of disclosure on adherence to antiretroviral therapy among adults living with HIV in Ethiopia: a systematic review and meta-analysis","volume":"19","author":"Dessie","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/hiv.13005","article-title":"Non-disclosure of HIV serostatus to sexual partners: prevalence, risk factors and clinical impact in patients with HIV","volume":"22","author":"Morkphrom","year":"2021","journal-title":"HIV Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e0126026","DOI":"10.1371\/journal.pone.0126026","article-title":"Magnitude and predictors of anti-retroviral treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia","volume":"10","author":"Teshome Yimer","year":"2015","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/HIV.S139516","article-title":"Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case\u2013control study","volume":"9","author":"Bayu","year":"2017","journal-title":"HIV\/AIDS-Research and Palliative Care"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00336-0","article-title":"Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis","volume":"18","author":"Mesic","year":"2021","journal-title":"AIDS Res Ther"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10461-019-02456-1","article-title":"Hiv disclosure to family members and medication adherence: role of social support and self-efficacy","volume":"24","author":"Mi","year":"2020","journal-title":"AIDS Behav"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-6405-11-5","article-title":"HIV serostatus disclosure among people living with HIV\/AIDS in Mwanza, Tanzania","volume":"11","author":"Yonah","year":"2014","journal-title":"AIDS Res Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e0171780","DOI":"10.1371\/journal.pone.0171780","article-title":"High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015","volume":"12","author":"Kyaw","year":"2017","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/jac\/dkw051","article-title":"HIV virological failure and drug resistance in a cohort of Tanzanian people with HIV (PWH) adults","volume":"71","author":"Hawkins","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1093\/jac\/dkv143","article-title":"Determinants of virological failure and antiretroviral drug resistance in Mozambique","volume":"70","author":"Rup\u00e9rez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.11604\/pamj.2015.21.291.6831","article-title":"Assessment of the magnitude and associated factors of immunological failure among adult and adolescent people with HIV (PWH) patients in St. Luke and Tulubolo hospital, Oromia region, Ethiopia","volume":"21","author":"Bayou","year":"2015","journal-title":"Pan Afr Med J"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.9734\/jammr\/2020\/v32i330388","article-title":"Factors influencing viral load non-suppression among people living with HIV (PLHIV) in Borno state, Nigeria: a case of Umaru Shehu ultra-modern hospital","volume":"32","author":"Sunkanmi","year":"2020","journal-title":"J Adv Med Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e0258930","DOI":"10.1371\/journal.pone.0258930","article-title":"Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl specialized hospital, south West Ethiopia; a case control study","volume":"16","author":"Zenu","year":"2021","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e0229550","DOI":"10.1371\/journal.pone.0229550","article-title":"Correlation between the immuno-virological response and the nutritional profile of treatment-experienced people with HIV (PWH) patients in the east region of Cameroon","volume":"16","author":"Abba","year":"2021","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/hiv.13017","article-title":"Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV","volume":"22","author":"Han","year":"2021","journal-title":"HIV Med"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1952-x","article-title":"Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in northwestern Uganda","volume":"16","author":"Izudi","year":"2016","journal-title":"BMC Infect Dis"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hiv.12708","article-title":"Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps","volume":"20","author":"Boyd","year":"2019","journal-title":"HIV Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3967\/bes2020.039","article-title":"Benefits of early and immediate initiation of antiretroviral therapy among HIV patients in Chongqing, China","volume":"33","author":"Zhou","year":"2020","journal-title":"Biomed Environ Sci"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/QAD.0000000000002124","article-title":"RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population","volume":"33","author":"Coffey","year":"2019","journal-title":"AIDS (London, England)"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1056\/NEJMoa1904340","article-title":"Dolutegravir-based or low-dose Efavirenz-based regimen for the treatment of HIV-1","volume":"381","author":"Kouanfack","year":"2019","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society\u2013USA panel","volume":"316","author":"G\u00fcnthard","year":"2016","journal-title":"JAMA"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1016\/S2352-3018(19)30400-X","article-title":"Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines","volume":"7","author":"Phillips","year":"2020","journal-title":"Lancet HIV"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1086\/522991","article-title":"Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among people with HIV (PWH) adults receiving antiretroviral therapy in Tanzania","volume":"45","author":"Ramadhani","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1440504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:22:18Z","timestamp":1748827338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1440504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":62,"alternative-id":["10.3389\/fpubh.2025.1440504"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1440504","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"article-number":"1440504"}}